These data suggest that metastatic prostate cancer cell migration involves cooperation between tumor-associated Endo180 and LOX-dependent crosslinking in human fibroblast-derived ECM but not osteoblast-derived ECM. The gene discussed is MRC2; the disease is metastatic prostate carcinoma.